TY - JOUR
T1 - Acute Hemolytic Anemia with Rigid Red Cells in Hypophosphatemia
AU - Jacob, Harry S
AU - Amsden, Thomas
PY - 1971/12/23
Y1 - 1971/12/23
N2 - Severe, but reversible, hemolytic anemia occurred in a patient with profound hypophosphatemia (serum phosphorus less than 0.1 mg per 100 ml). Red-cell ATP and 2,3 DPG were markedly depressed during the hypophosphatemic period (to 11 and 30 per cent of normal, respectively). The striking reduction in red-cell ATP was associated with microspherocytic morphology, increased rigidity and diminished survival of the affected cells. All variables returned to normal after parenteral phosphate supplementation. The more than twofold increase in rigidity of ATP-deficient red cells was corrected by incubation with adenosine for two hours, so as to generate intracellular ATP. In addition to the hemolytic process, tissue oxygenation was probably further curtailed during the hypophosphatemic period because of the lowered red-cell 2,3 DPG and ATP levels. Hypophosphatemia may thus have profound, deleterious effects on the viability of human red cells.
AB - Severe, but reversible, hemolytic anemia occurred in a patient with profound hypophosphatemia (serum phosphorus less than 0.1 mg per 100 ml). Red-cell ATP and 2,3 DPG were markedly depressed during the hypophosphatemic period (to 11 and 30 per cent of normal, respectively). The striking reduction in red-cell ATP was associated with microspherocytic morphology, increased rigidity and diminished survival of the affected cells. All variables returned to normal after parenteral phosphate supplementation. The more than twofold increase in rigidity of ATP-deficient red cells was corrected by incubation with adenosine for two hours, so as to generate intracellular ATP. In addition to the hemolytic process, tissue oxygenation was probably further curtailed during the hypophosphatemic period because of the lowered red-cell 2,3 DPG and ATP levels. Hypophosphatemia may thus have profound, deleterious effects on the viability of human red cells.
UR - http://www.scopus.com/inward/record.url?scp=0015237874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015237874&partnerID=8YFLogxK
U2 - 10.1056/NEJM197112232852602
DO - 10.1056/NEJM197112232852602
M3 - Article
C2 - 5122895
AN - SCOPUS:0015237874
SN - 0028-4793
VL - 285
SP - 1446
EP - 1450
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 26
ER -